CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- 8-K Event Results of operations
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- 8-A12B Other Registration of Securities
- 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change · Other events
- 15-12B Other 15-12B
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 100,000 shares at $1.00 ($100,000)
- 4 Open-market buy Director bought 100,000 shares at $1.00 ($100,000)
- 4 Open-market buy EVP, CFO bought 30,000 shares at $1.00 ($30,000)
Page 17 of 50 · 1,000 filings